Competitors are wobblingOur abysmal SP aside, considering the frustrations everyone is feeling, notiwthstanding the GG role out, sometimes it's nice to see the fall from grace our biggest competitors are showcasing consistently.
Labs - $0.70 -> $0.20, and
Valens $6.84 (and a mid year high of $11.82) -> $2.36
Valens and Labs have been Hemoragging value this entire year, even in the face of multiple NR's and apparent net new B2B partners. I'm more wary of a once reputable company that releases plenty of news that appears positive on the surface, but is clearly losing footing because of the new compressed margin environemnt they need to compete in.
Our solution is more contracts and more vapes sold, status quo. They'd need to completely retool their tech to begin competiing at our level to sustain SP. Very different challenges.
Happy Friday everyone.